Drug Shortage Report for TEVA-CLONIDINE

Last updated on 2025-03-13 History
Report ID 242344
Drug Identification Number 02046121
Brand name TEVA-CLONIDINE
Common or Proper name TEVA-CLONIDINE 0.1MG TAB
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) CLONIDINE HYDROCHLORIDE
Strength(s) 0.1MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 100
ATC code C02AC
ATC description ANTIADRENERGIC AGENTS, CENTRALLY ACTING
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2024-11-07
Estimated end date 2025-03-20
Actual end date
Shortage status Actual shortage
Updated date 2025-03-13
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v18 2025-03-13 French Compare
v17 2025-03-13 English Compare
v16 2025-02-28 French Compare
v15 2025-02-28 English Compare
v14 2025-02-13 French Compare
v13 2025-02-13 English Compare
v12 2025-01-30 French Compare
v11 2025-01-30 English Compare
v10 2025-01-16 French Compare
v9 2025-01-16 English Compare
v8 2024-11-28 French Compare
v7 2024-11-28 English Compare
v6 2024-11-21 French Compare
v5 2024-11-21 English Compare
v4 2024-11-14 French Compare
v3 2024-11-14 English Compare
v2 2024-11-08 French Compare
v1 2024-11-08 English Compare

Showing 1 to 18 of 18